Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Advanced Micro Devices (AMD) vs Baxter International Inc (BAX) Price & Performance

Advanced Micro DevicesTrade
Baxter International IncTrade

Price performance (Past 24H)

Key statistics

Advanced Micro Devices vs Baxter International Inc — how do they compare? Advanced Micro Devices trades at $473.51 (market cap $766.54B), while Baxter International Inc trades at $27.61 (market cap $14.36B). The key difference: Advanced Micro Devices is far larger — about 53.4× Baxter International Inc's market cap, and Baxter International Inc pays a 0.14% dividend while Advanced Micro Devices pays none. Which is the better fit depends on your goals.

AMDBAX
Market Cap
$766.54B$14.36B
Sector
TechnologyHealth
52-Week High
$580.91$28.35
52-Week Low
$151.14$15.80
Enterprise Value
$757.71B$21.88B
Dividend Yield
0.14%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Advanced Micro Devices

AMD trades at $474.32, down 1.87% on the day, with a bearish technical signal but strong fundamental momentum. The stock shows elevated valuation metrics (P/E 119.79, P/S 18.75) despite impressive revenue growth to $34.64B in 2025 and consistent earnings beats. Analyst consensus remains strongly bullish with a $615.11 price target, while recent news highlights AMD's positioning in the competitive AI semiconductor market.

AMD presents a growth story driven by AI and data center demand, with projected revenue reaching $41.3B in 2026. However, high valuations and intense competition from NVIDIA represent significant risks. The stock offers substantial upside to analyst targets but requires careful monitoring of execution and market share dynamics.

Baxter International Inc

Baxter International (BAX) trades at $27.55, up 2.0% today, showing strong momentum after recent earnings beats. The stock is approaching its 52-week high of $29.35, with technical indicators signaling bullish momentum. Fundamentally, the company reported Q2 2026 earnings of $0.56 per share, beating estimates, and raised full-year guidance, though profitability metrics remain negative with a -9.27% net income margin. Recent news highlights operational improvements and strong demand for IV solutions.

The outlook is cautiously optimistic as Baxter demonstrates turnaround progress with raised guidance and earnings beats. Investment opportunity lies in continued operational execution and margin recovery, but risks include persistent negative profitability, high debt levels, and competitive pressures in the medtech space. Wall Street sentiment is mixed with 42% buy ratings but a consensus price target below current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Advanced Micro Devices

Advanced Micro Devices, Inc. (AMD) produces semiconductor products and devices. The Company offers products such as microprocessors, embedded microprocessors, chipsets, graphics, video and multimedia products and supplies it to third-party foundries, as well as provides assembling, testing, and packaging services. AMD serves customers worldwide.

Read more on AMD

About Baxter International Inc

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.

Read more on BAX